The role of 18F‐FDG‐PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients

Sung Hoon Yang, Kyung‐Suk Suh, Hae Won Lee, Eung‐Ho Cho, Jai Young Cho, Yong Beom Cho, Nam‐Joon Yi, Kuhn Uk Lee – 8 September 2006 – Positron emission tomography (PET) using F‐18 fluoro‐2‐deoxy‐d‐glucose (18F‐FDG) is now well established as a noninvasive diagnostic tool for the detection of a variety of malignant tumors. However, in the case of hepatocellular carcinoma (HCC), several investigators have reported controversial conclusions and an inadequate sensitivity for PET (50‐55%).

Impact of UCSF criteria according to pre‐ and post‐OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time

Thomas Decaens, Françoise Roudot‐Thoraval, Solange Hadni‐Bresson, Carole Meyer, Jean Gugenheim, Francois Durand, Pierre‐Henri Bernard, Olivier Boillot, Laurent Sulpice, Yvon Calmus, Jean Hardwigsen, Christian Ducerf, Georges‐Philippe Pageaux, Sebastien Dharancy, Olivier Chazouilleres, Daniel Cherqui, Christophe Duvoux – 8 September 2006 – Orthotopic liver transplantation (OLT) indication for hepatocellular carcinoma (HCC) is currently based on the Milan criteria.

Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation

Giuseppe Fusai, Parveen Dhaliwal, Nancy Rolando, Caroline Anne Sabin, David Patch, Brian Ritchie Davidson, Andrew Kenneth Burroughs, Keith Rolles – 1 September 2006 – Predictive factors for intrahepatic cholestasis after orthotopic liver transplantation (OLT) have not yet been established. We sought to identify the incidence and risk factors associated with prolonged severe intrahepatic cholestasis (PSIC) after OLT. We assessed 428 consecutive patients undergoing their first OLT.

Subscribe to